Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-07-18 4:45 pm Purchase |
2022-07-07 | 13D | Annexon, Inc. ANNX |
Satter Muneer A | 5,032,463 10.400% |
3,077,485 (+157.42%) |
Filing History |
| 2022-07-18 4:30 pm Purchase |
2022-07-07 | 13G | Annexon, Inc. ANNX |
ADAGE CAPITAL PARTNERS GP L.L.C. | 4,184,561 8.680% |
4,184,561 (New Position) |
Filing History |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | Annexon, Inc. ANNX |
BlackRock Inc. BLK |
961,043 2.500% |
-1,653,548 (-63.24%) |
Filing History |
| 2022-06-23 4:05 pm Purchase |
2022-06-13 | 13G | Annexon, Inc. ANNX |
Venrock Healthcare Capital Partners II, L.P. | 1,928,477 5.000% |
1,928,477 (New Position) |
Filing History |
| 2022-05-26 5:09 pm Purchase |
2022-05-16 | 13G | Annexon, Inc. ANNX |
BIOTECHNOLOGY VALUE FUND L P | 3,343,194 8.700% |
3,343,194 (New Position) |
Filing History |
| 2022-04-21 10:00 am Purchase |
2022-04-11 | 13G | Annexon, Inc. ANNX |
Fairmount Funds Management LLC | 2,569,400 6.700% |
2,569,400 (New Position) |
Filing History |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Annexon, Inc. ANNX |
Redmile Group LLC | 3,228,917 8.400% |
-219,113 (-6.35%) |
Filing History |
| 2022-02-14 3:54 pm Purchase |
2022-02-14 | 13G | Annexon, Inc. ANNX |
ALLIANCEBERNSTEIN L.P. | 2,064,005 5.400% |
2,064,005 (New Position) |
Filing History |
| 2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Annexon, Inc. ANNX |
T. Rowe Price Associates, Inc. | 2,876,667 7.400% |
2,876,667 (New Position) |
Filing History |
| 2022-02-14 1:37 pm Purchase |
2021-12-31 | 13G | Annexon, Inc. ANNX |
FEDERATED HERMES INC. FHI |
2,025,600 5.280% |
2,025,600 (New Position) |
Filing History |
| 2022-02-14 11:39 am Purchase |
2021-12-31 | 13G | Annexon, Inc. ANNX |
Eventide Asset Management, LLC | 2,850,000 7.400% |
845,384 (+42.17%) |
Filing History |
| 2022-02-14 06:19 am Sale |
2021-12-31 | 13G | Annexon, Inc. ANNX |
Citadel Advisors LLC | 1,482,022 3.900% |
-654,093 (-30.62%) |
Filing History |
| 2022-02-11 4:30 pm Sale |
2021-12-31 | 13G | Annexon, Inc. ANNX |
Novartis Bioventures Ltd | 910,747 2.370% |
-1,196,497 (-56.78%) |
Filing History |
| 2022-02-10 11:16 am Purchase |
2022-02-09 | 13G | Annexon, Inc. ANNX |
PICTET ASSET MANAGEMENT SA | 58,684 5.630% |
58,684 (New Position) |
Filing History |
| 2022-02-09 09:09 am Sale |
2022-02-08 | 13G | Annexon, Inc. ANNX |
FMR LLC | 1,340,027 3.491% |
-860,859 (-39.11%) |
Filing History |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Annexon, Inc. ANNX |
BlackRock Inc. BLK |
2,614,591 6.800% |
127,258 (+5.12%) |
Filing History |
| 2021-11-19 06:45 am Sale |
2021-11-04 | 13G | Annexon, Inc. ANNX |
New Enterprise Associates 15 L.P. | 0 0.000% |
-2,495,687 (Position Closed) |
Filing History |
| 2021-08-27 4:50 pm Sale |
2021-08-18 | 13D | Annexon, Inc. ANNX |
Blackstone Holdings II L.P. | 1,820,423 4.700% |
-910,212 (-33.33%) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | Annexon, Inc. ANNX |
Citadel Advisors LLC | 2,136,115 5.600% |
15,782 (+0.74%) |
Filing History |
| 2021-02-16 4:06 pm Purchase |
2020-12-31 | 13G | Annexon, Inc. ANNX |
Redmile Group LLC | 3,448,030 9.040% |
3,448,030 (New Position) |
Filing History |